Tokyo Health Walk 2026 invites residents to participate in a unique event promoting fitness and free colon cancer screenings. Join us!

Abbott, in partnership with actress Gabriela Spanic, launches a campaign aimed at increasing awareness and early detection of colon cancer in the Hispanic community through Cologuard Plus® screening.

A Spanish study reveals that participants in a 21-year program using at-home fecal immunochemical tests (FIT) experienced a 50% reduction in colon cancer mortality among adults aged 50-69. The non-invasive test, which requires no preparation and can be done at home, involves collecting a stool sample for lab analysis. Researchers analyzed data from 2.2 million people, highlighting the FIT's effectiveness compared to traditional methods like colonoscopies. While FITs are less costly and more accessible, they are not a replacement for colonoscopies, which can detect and remove precancerous polyps. The study emphasizes that early detection through affordable screening options like FITs can significantly reduce cancer-related deaths, particularly for those unable to access regular colonoscopies.

A groundbreaking study led by Dr. Stacy Norton, a Houston-based doctor with Lynch syndrome, is exploring a potential vaccine to prevent colon cancer in high-risk individuals. Lynch syndrome, an inherited genetic disorder, significantly increases the risk of colorectal and other cancers. Current treatments involve frequent colonoscopies, but scientists are developing vaccines that could train the immune system to detect and eliminate precancerous cells before they develop into tumors. The trial tested a vaccine from Swiss biotech Nouscom, which reduced precancerous growths in Lynch syndrome carriers by stimulating tumor-eliminating T cells. Researchers at MD Anderson Cancer Center reported promising results, with participants showing fewer polyps and no advanced growths after a year. Other trials by Moderna and ImmunityBio are also underway, aiming to create vaccines targeting genetic mutations linked to cancer. The study highlights hope for patients like Norton, who have a family history of early-onset cancers, offering a potential alternative to lifelong colonoscopies. Experts emphasize the importance of genetic testing for Lynch syndrome carriers and suggest broader screening guidelines for at-risk populations.

Instead of destroying cancer cells, this new technology transforms colon cancer cells into normal-like cells.

Discover a unique toilet paper that promotes colon cancer screening through eye-catching designs. It aims to raise awareness in daily life.

Human Longevity, Inc. is enhancing its $1 million cancer pledge to prioritize colon cancer prevention, pioneering proactive early detection methods for better health outcomes.

Georgia CORE unveils the 'Weird Looking Stools' campaign, aiming to raise awareness about colon cancer through artistic stools in local bars and cafes.

Viome Life Sciences and Scripps Research team up to create the first at-home RNA screening test aimed at preventing colon cancer. The study will involve 1,000 patients to analyze RNA data for early detection.

AMSURG emphasizes the importance of early colon cancer screening as rates rise, especially among young adults. Their campaign aims to educate and improve access to life-saving colonoscopies.

Colon cancer used to be seen mainly in seniors. It's now showing up in young adults. Ultra-processed foods are a factor, a new study finds.